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Ca21 Signaling Pattern in CD41CD81 Thymocytes
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Summary
Thymocyte maturation is governed by antigen–T cell receptor (TCR) affinity and the extent
of TCR aggregation. Signals provided by coactivating molecules such as CD4 and CD28
also influence the fate of immature thymocytes. The mechanism by which differences in antigen–TCR avidity encode unique maturational responses of lymphocytes and the influence of
coactivating molecules on these signaling processes is not fully understood. To better understand the role of a key second messenger, calcium, in governing thymocyte maturation, we
measured the intracellular free calcium concentration ([Ca21]i) response to changes in TCR
avidity and costimulation. We found that TCR stimulation initiates either amplitude- or frequency-encoded [Ca21]i changes depending on (a) the maturation state of stimulated thymocytes, (b) the avidity of TCR interactions, and (c) the participation of specific coactivating
molecules. Calcium signaling within immature but not mature thymocytes could be modulated
by the avidity of CD3/CD4 engagement. Low avidity interactions induced biphasic calcium responses, whereas high avidity engagement initiated oscillatory calcium changes. Notably, CD28
participation converted the calcium response to low avidity receptor engagement from a biphasic to oscillatory pattern. These data suggest that calcium plays a central role in encoding the nature of the TCR signal received by thymocytes and, consequently, a role in thymic selection.
Key words: selection • avidity • TCR • CD4 • CD28

T

hymocyte development is governed by interactions
between Ags, expressed on the surface of stromal cells
within the thymus, and TCRs. CD41CD81 double-positive (DP)1 thymocytes are primary targets of selection
events that shape the T cell repertoire. The fate of a DP
thymocyte is determined both by the affinity of Ag–TCR
engagement and by the extent of receptor aggregation induced by this interaction, influences collectively referred to
as avidity (1–3). Thus, high avidity Ag–TCR interactions
are required for the removal of developing thymocytes
from the T cell pool (negative selection), whereas lower
avidity TCR–Ag interactions initiate maturation (positive
selection) (4). The signaling processes evoked by high or
low avidity engagement and the subsequent steps leading to
different developmental responses are not fully understood.
TCR engagement alone appears insufficient to promote
either cell death or differentiation, regardless of the affinity
of the interaction. Coactivating/costimulating molecules
engaged by ligands expressed on stromal cells cooperate
with the TCR to determine the fate of immature DP thy1Abbreviation

used in this paper: DP, double-positive.
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mocytes. For example, signals provided by the TCR and
CD2 or CD4 induce positive selection of CD41CD81 thymocytes in vitro (5, 6). Negative selection of CD41CD81
thymocytes also requires a second signal, which can be provided by the costimulatory molecule CD28 (7–9).
Calcium has been implicated as an essential second messenger during lymphocyte maturation and differentiation
(10–13). Unique calcium signaling responses are associated
with distinct patterns of transcription factor expression or
maturation. For example, in thymocytes, the mean amplitude of antigen-induced calcium signals and the developmental fate vary with the affinity of an Ag–TCR interaction
(14). In these cells, high affinity peptide–TCR interactions
evoke high amplitude calcium elevations and negative selection, whereas low affinity peptide–TCR interactions
evoke low amplitude calcium elevations and positive selection. In naive peripheral B lymphocytes, the amplitude of
experimentally regulated calcium elevations determines which
transcription factors are activated (15), whereas in resting
peripheral human T lymphocytes, oscillating intracellular
calcium (Ca21i) changes induce specific transcription factors
by reducing their effective threshold for calcium activation
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(16). Different calcium signaling responses may also underlie distinct functional states of lymphocytes. For example,
antigen evokes a biphasic calcium response in naive B cells
but induces calcium oscillations in tolerant B cells (17).
These data collectively suggest that amplitude- and frequencymodulated calcium signals can encode distinct cellular responses of lymphocytes. However, the receptor interactions that define each pattern of calcium signaling are not
fully understood.
Given that immature CD41CD81 thymocytes exhibit
distinct developmental responses depending upon the nature of the TCR signal they receive, we examined the calcium responses to distinct TCR-mediated signals. We show
that TCR signaling can be encoded either as amplitude differences or oscillatory changes in Ca21i depending on (a)
the maturation state of the stimulated thymocytes, (b) the
avidity of an TCR interaction, and (c) the coreceptor involved in the engagement.

Materials and Methods
Thymocyte Preparation. Thymi were obtained from adult or
fetal C57Bl/6 mice. Intact lobes were placed in a small volume of
DMEM without NaHCO 3 and phenol red. The tonicity of the
basal medium was adjusted to 310 mOsm with z1.6 g of NaCl
per liter and supplemented with 10 mM Hepes buffer, 5% heatinactivated fetal bovine serum, and 1 mM l-glutamine. Thymocytes were released by gently tearing open the capsule with small
forceps. Noncellular material was removed by filtering this preparation through 70 mM nylon mesh. The filtered preparation was
maintained at room temperature, and aliquots were used for calcium measurements without further manipulation.
Single-Cell Fluorescence Measurements. Murine thymocytes were
loaded with the cell-permeant calcium indicator fura-2 acetoxymethyl ester (AM, 3.0 mM; Molecular Probes, Inc.) in DMEM for 10
min at room temperature (25 8C), placed into the recording
chamber on an inverted fluorescent microscope (Nikon Inc.),
and allowed to adhere to Poly-D-lysine (100 mg/ml; Sigma
Chemical Co.) treated coverslips for 5 min. Ca 21i was measured
at room temperature unless indicated otherwise. We observed no
measurable difference in the calcium signaling response at 25 vs.
378C. mAbs to relevant surface receptors were added to thymocyte suspensions during the final 10 min of fura-2 loading.
Excess extracellular fura-2 AM and unbound antibody was
washed away by perfusing the microscope recording chamber
with extracellular bath solution for 5 min. The bath solution consisted of 155 mM NaCl, 4.5 mM KCl, 2 mM CaCl 2, 1 mM MgCl2,
5 mM glucose, and 10 mM Hepes and was adjusted to pH 7.4. Discrete bandwidth excitation light (340 6 10 nm, 380 6 10 nm)
from a xenon source coupled to a computer-controlled monochromator (TILL; Applied Scientific Imaging) was directed to the epifluorescence attachment of the microscope through a small quartz
fiber-optic guide. Excitation light was directed to the fluorescence
objective (1003; Nikon Inc.) via a dichroic mirror. The emitted
fluorescence from the fura-2–loaded cells passed through a 470-nmlong pass filter, and images were obtained with an intensified
charge–coupled video camera (model C2400-68; Hammamatsu
Phototonics) connected to the side port of the inverted microscope. Four fluorescent video images were averaged and digitized
(0.5 Hz) with a video frame grabber (Matrox) using Metafluor acquisition and analysis software (Universal Imaging Corp.). Stored
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images were analyzed off-line using the Metafluor package.
Within cursor-defined areas of interest, paired 340/380 images were
background subtracted and the ratio was calculated. The absolute
ratio values in the cursor-defined areas were exported into Microsoft Excel and converted to [Ca21] (18). In situ calibration factors, Rmax (340/380 ratio obtained in presence of 5 mM ionomycin and 10 mM Ca 21), Rmin (340/380 ratio in presence of 5
mM ionomycin and excess EGTA), and F380max, and F380min
(maximum and minimum 510 nm emission with 380 nm excitation) were determined. The values obtained for Rmin, Rmax, F380min,
and F380max were 0.25, 20.0, 40, and 100, respectively, and a dissociation constant (Kd) of 224 was used for fura-2.
Antibodies and Receptor Aggregation. Biotin-conjugated mAbs
specific for CD4 (RM4-5, PharMingen), TCR (H57-597),
CD28 (37.51, PharMingen), CD5 (53-7.3, PharMingen), CD3
(145-2C11, PharMingen), and CD28 (37.51, PharMingen) were
used to activate thymocytes. Calcium signaling responses were
initiated by aggregating antibody-bound surface receptors with
streptavidin, which was added to the recording chamber. For
routine measurements, streptavidin was added to the bath at a final concentration of 0.25–0.5 mg/ml. In several calcium experiments, polystyrene microspheres (5 mM diameter; Interfacial Dynamics Corp.) were used to aggregate surface receptors. Cells
were first treated with biotin-conjugated antibodies against relevant receptors (see Results), and these antibody-bound receptors
were aggregated with streptavidin-coated (0.5–1.0 mg/ml) polystyrene microspheres (Interfacial Dynamics Corp.). Microspheres
(106) were prepared by incubation (1.5 h, 37 8C) with aCD28
(5 mg/ml) and/or aCD3 (1 mg/ml) and aCD4 (1mg/ml), and
were rinsed three times with PBS containing 1% BSA. Antibodytreated microspheres were cultured at a 1:1 ratio with CD4 1
CD81 thymocytes. The functional responses were determined
after 16–20 h of incubation.
Thymocyte Phenotyping. In some experiments, after measuring
Ca21i, surface CD4, CD8, and CD5 expression levels were determined for each cell. Antibodies (PharMingen) against CD8 (53-6.7,
FITC), CD5 (53-7.3, PE) and CD4 (RM4-5, Cy-Chrome) were
added directly to the microscope chamber (15 min, 25 8C), and
unbound antibody was removed by perfusion with bath solution
(5 min). Digital images were collected sequentially for each fluorochrome. Three separate filter cubes (Chroma Technologies) were
used to image FITC, PE, and Cy-Chrome fluorescence. These
digital images were first used to determine the CD4/CD8 phenotype of each cell. The activation/maturation state of CD4 1CD81
thymocytes was further refined based upon the level of CD5 expression. A value for the CD5 fluorescence intensity was obtained at an intermediate focal plane for each cell in the image
field to identify CD5low, CD5int, and CD5high cells. Thymocytes
were grouped simply according to average percentages obtained
for each population from flow cytometric analysis. Thus, 30% of
cells with the lowest CD5 intensities were designated as CD5 low
cells, 55% of cells as CD5int., and 15% of cells as CD5high.

Results
TCR/CD3-mediated Maturation and Death Signals Induce
Distinct Ca21i Signaling Responses. To determine whether
distinct TCR-mediated stimuli evoke distinct calcium responses in immature T cells, we measured the intracellular
free calcium concentration ([Ca21]i) in individual thymocytes after coengagement of surface molecules that induce
either maturation (CD4 and TCR or CD3; reference 5) or
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apoptosis (CD28 and TCR or CD3; reference 7). Each of
these costimulatory receptors had a distinct effect on TCR/
CD3-mediated Ca21 signaling within individual thymocytes (Fig. 1). Maturation stimuli (TCR/CD4 or CD3/
CD4) evoked two different patterns of calcium signaling.
Responding cells (z75%) typically exhibited an initial
rapid [Ca21]i elevation, which peaked within 30 s and decayed (Fig. 1, A and B). After the initial rise, [Ca21]i either
decreased to an elevated steady state (biphasic response) or
exhibited repetitive two- to fourfold elevations (spikes)
above resting levels. In spiking cells, the frequency was
similar for both CD3/CD4 (0.013 Hz)- and TCR/CD4
(0.010 Hz)-stimulated thymocytes (Fig. 1, A and B). Apoptotic stimuli (CD3 and CD28 coengagement) evoked a
limited [Ca21]i response in a small proportion (z25%) of
thymocytes. Although [Ca21i] spikes were observed in a
few CD3/CD28-stimulated cells (z10%), none of these
thymocytes exhibited a large initial [Ca21]i transient (Fig. 1 C).
Moreover, the response to CD3/CD28 was indistinguishable from the response to CD3 alone (Fig. 1 D).
The Pattern of Ca21 Signaling Reflects the Thymocyte Maturation Status. We were interested in examining the basis
for the different patterns of CD3/CD4-mediated Ca21 signaling and reasoned that they may reflect the responses of
cells in different maturational states. We tested this hypothesis first by comparing [Ca21]i signaling responses initiated
by CD3/CD4 coengagement in two isolated populations
representative of the most immature and mature TCR1
cells (Fig. 2). Immature thymocytes isolated from the day
17 fetal thymus contained no mature subpopulations and
displayed a markedly homogeneous spiking [Ca21]i response

Figure 1. Thymocyte calcium signaling is dependent upon the coreceptor that is coengaged with TCR/CD3. Unfractionated murine thymocytes were incubated with biotin-conjugated antibodies to CD3 and
CD4 (A), TCR and CD4 (B), CD3 and CD28 (C), and CD3 alone (D),
and calcium signaling was initiated by the addition of streptavidin (0.5
mg/ml) to the recording chamber (arrow). Each panel is representative of
similar results obtained in at least 10 separate experiments. The mean response of all cells is shown for each experiment (bold line).

945

Freedman et al.

Figure 2. Different CD3/CD4-evoked calcium signaling patterns in
mature and immature lymphocytes. Single-cell [Ca21]i changes triggered
by coaggregation of surface CD3 and CD4. (A) Thymocytes isolated
from day 17 fetal thymi were stimulated by bath addition of streptavidin
(0.5 mg/ml) at the indicated time (arrow). The majority of cells had either a CD42CD82 (49.5%) or CD41CD81 (39.3%) phenotype. No
TCRhigh cells were identified in these populations, although a proportion
of DP thymocytes expressed intermediate levels of TCR (data not
shown). Only responding thymocytes (17% of all cells) are shown. (B)
Lymph node lymphocytes were labeled with biotin-conjugated anti-CD3
and anti-CD4 and were stimulated by bath addition of streptavidin (0.5
mg/ml; arrow) to the recording chamber. Shown is the response of several CD41 cells, which were identified immediately after the Ca21i measurement by in situ staining with PE-conjugated anti-CD4 mAb. These
responses are typical of at least three separate experiments.

(Fig. 2 A). Conversely, all responding mature peripheral
CD41 T lymphocytes exhibited a biphasic [Ca21]i response
after CD3/CD4 coengagement, and [Ca21]i spikes were
never observed (Fig. 2 B). These results suggest that the
TCR/CD3-mediated calcium response is determined, at
least in part, by the maturation state of each lymphocyte.
We next examined CD3/CD4-mediated signaling in each
major thymocyte subpopulation to identify the precise maturational stage at which the [Ca21]i signaling response changes
from a spiking to a biphasic pattern. Rather than purify cells
of each maturational state, we recorded CD3/CD4-initiated
calcium responses within freshly isolated unfractionated
thymocytes and subsequently determined the maturation
phenotype of each cell. We were able to distinguish multiple
thymocyte subpopulations at distinct developmental stages
by staining for surface CD4, CD8, and CD5 (Fig. 3).
As expected, the most immature thymocytes (double
negative, CD42CD82CD5low) did not respond to CD3/
CD4 stimulation, presumably because they do not express

Figure 3. TCR/CD4-mediated calcium
responses of phenotypically defined thymocytes. Single-cell video imaging was used to
measure Ca21i within all thymocytes in a
1003 objective field. Biotin-conjugated,
mAb-labeled surface CD3 and CD4 were
aggregated by addition of streptavidin (0.5
mg/ml) to the bath chamber (arrows). The
[Ca21]i is plotted for individual thymocytes
(identified in the bright field image by number) to demonstrate differences in the calcium
signaling pattern associated with each maturation phenotype. The composite CD4/
CD8/CD5 phenotype of each cell was determined by manually analyzing separate fluorescent images obtained for each receptor in
situ, and the aggregate thymocyte phenotype
is indicated. The cells shown are representative of all cells of similar phenotype in this
experiment, and these data are from three
similar experiments. Experiments 1 and 2
were performed at 258C, and experiment 3
was performed at 378C.

CD3. Two subpopulations of CD41CD81 thymocytes
were clearly distinguishable by differences in surface levels
of the maturation/activation marker, CD5 (19). Immature
DP (CD41CD81CD5low/int) thymocytes, the bulk of immature T cells in the thymus, responded with an initial
transient [Ca21]i elevation followed by Ca21 spikes. These
[Ca21]i spikes often originated from and returned to the
resting baseline level and continued for more than 20 min.
Mature CD41CD81CD5high thymocytes typically exhibited a biphasic [Ca21]i change with little spiking activity,
whereas the most mature (CD41CD82CD5high) thymocytes exhibited a pure biphasic response. These results suggest that the capacity of thymocytes to generate calcium
spikes is developmentally restricted in the mouse to the immature CD41CD81 thymocyte stage.
Regulation of Calcium Oscillations in Immature Thymocytes
by the Extent of Receptor Aggregation. The molecular basis
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for different TCR/CD3-mediated developmental responses
of CD41CD81 thymocytes is unknown but clearly governed by the strength of TCR engagement and could arise
from differences in the proximal signals generated, including calcium. We therefore examined the relationship between the [Ca21]i response pattern and the strength or
avidity of the TCR signal. We quantitatively varied the
signal strength in our system by modulating the extent of
CD3/CD4 coaggregation. To do this, we systematically altered the concentration of streptavidin used to cross-link
the stimulating (biotinylated) antibodies, thereby altering
the degree of receptor aggregation. We reasoned that at
high concentrations, streptavidin would tend to form monovalent complexes with biotin, whereas at limiting concentrations, the tetravalent streptavidin would form large complexes
with multiple biotin molecules, resulting in aggregation of
biotinylated antibodies and their ligands (Fig. 4 A).

Calcium Signaling in Murine Thymocytes

Figure 4. The effect of maturation and receptor aggregation on calcium signaling in thymocytes. Streptavidin was
used to aggregate biotin-conjugated, mAb-labeled surface
receptors and trigger calcium signaling within thymocytes.
(A) Model of receptor aggregation by streptavidin. At high
concentrations of streptavidin (right; streptavidin/biotin ratio ..1), the majority of streptavidin molecules should
form monovalent complexes with biotin (stoichiometry of
1:1), resulting in minimal receptor aggregation. At lower
streptavidin levels, the biotin/streptavidin stoichiometry
will approach 4, resulting in higher receptor aggregation,
although the overall number of receptors engaged would
begin to decrease as streptavidin became limiting. Maximal
receptor aggregation occurs over an intermediate range of
streptavidin concentrations. (B) Thymocytes were labeled
with biotin-conjugated anti-CD3 and anti-CD4, and separate
aliquots were treated with different streptavidin concentrations (0.25–10 mg/ml). Available biotin and streptavidin
binding sites were identified by incubating thymocytes
with R670-conjugated streptavidin or PE-conjugated biotin, respectively. The relative maximum PE and R670 fluorescence intensities are plotted against the cross-linking
streptavidin concentration.

To verify this strategy, we evaluated the extent of receptor aggregation by assessing the presence of unbound biotin
molecules on antibody and unoccupied biotin-binding sites
on streptavidin. We detected unbound biotin molecules and
unoccupied biotin-binding sites by treating cells prepared for
stimulation with R670-conjugated streptavidin (R670–SA)
or PE-conjugated biotin (PE–biotin) (Fig. 4 B). Consistent
with the notion that maximal receptor aggregation occurs
at low streptavidin concentrations, PE–biotin bound minimally at limiting concentrations of aggregating streptavidin,
indicating that biotin-binding sites were fully occupied
(Fig. 4 B). Conversely, PE–biotin bound maximally at high
streptavidin concentrations, indicating that biotin-binding
sites on streptavidin were minimally occupied. We also
measured R670–SA binding to unbound, antibody-associated biotin to precisely determine the concentrations of aggregating streptavidin at which all antibody-associated biotin was maximally engaged. R670–SA binding decreased
progressively with increasing concentrations of aggregating
streptavidin (Fig. 4 B), indicating that antibody-associated
biotin was maximally engaged by aggregating streptavidin
at concentrations exceeding 1.0 mg/ml.
These data suggest that maximal antibody (and by inference, receptor) aggregation will occur at a streptavidin
concentration at which R670–SA and PE–biotin fluorescence are both minimal (i.e., when biotin and biotin binding sites are maximally engaged; Fig. 4 A). This occurs near
the intersection of the curves (Fig. 4 B). Thus, optimal aggregation of CD3 and CD4 can be achieved at 0.25–0.75
mg/ml of aggregating streptavidin, whereas minimal aggregation will occur at relatively high streptavidin concentrations (5 mg/ml), when biotin-binding sites on streptavidin
947
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exceed available biotin. The model presents an idealized interpretation of how streptavidin can be used to vary the extent of receptor–antibody aggregation. It should be noted
that primary antibodies used in these experiments are bivalent and could themselves cause a limited degree of crosslinking. Also, it is likely that even at very high concentrations, streptavidin would cross-link some antibody-bound
receptors. Thus, we use the term minimal aggregation to
describe this experimental condition.
Thymocyte Ca21 Signaling Patterns Vary with the Extent of
Receptor Aggregation. To evaluate the relationship between
receptor aggregation and calcium signaling, surface CD3
and CD4 were maximally (0.5 mg/ml streptavidin) or minimally (5.0 mg/ml streptavidin) aggregated, and calcium responses of individual thymocytes were grouped according
to the level of CD5 expression, a sensitive measure of
maturation status (19). The majority of immature, CD5low
(CD42CD82 and some CD41CD81) thymocytes were
relatively nonresponsive to receptor aggregation. A few,
presumably DP CD5low cells, exhibited calcium spikes (Fig.
5 A). The pattern of calcium signaling among these CD5low
responders was converted to a monophasic pattern under
conditions of minimal receptor aggregation (Fig. 5 B).
The Ca21i signaling pattern in immature, CD5int (CD41
CD81) thymocytes was also markedly affected by the extent
of receptor/coreceptor aggregation. Maximal receptor aggregation (0.5 mg/ml streptavidin) induced a relatively rapid
initial elevation of [Ca21]i, similar to that observed in mature
cells. However after z1 min, [Ca21]i decayed from its peak
level and a spiking (0.019 Hz) signaling response persisted in
most (26/45) responding cells (Fig. 5 C). Minimal aggregation of CD3 and CD4 receptors (5 mg/ml streptavidin) on

Figure 5. The effect of receptor aggregation on calcium signaling.
Ca21i signaling was induced by CD3/CD4 coaggregation in thymocytes
and peripheral CD41 lymphocytes under maximal (0.5 mg/ml) and minimal (5.0 mg/ml) aggregating conditions. The calcium responses of thymocytes are plotted together for cells expressing low (A and B), intermediate
(C and D), or high (E and F) levels of CD5. Several representative traces
are shown for each phenotype, and the mean response of all cells is indicated (bold line). The CD3/CD4-mediated calcium response in mature
peripheral CD41 lymphocytes is insensitive to the receptor aggregation
status. Calcium signaling was triggered by engagement of CD3 and CD4
with low (0.5 mg/ml; G) or high (5.0 mg/ml; H) streptavidin. CD41 cells
were identified within unpurified lymph node preps at the conclusion of
the calcium measurement with PE-conjugated anti-CD4. Several representative traces are shown for each condition. These data are representative of at least three separate experiments for each condition.

immature DP thymocytes evoked a biphasic [Ca21]i increase
in all responding cells. The initial mean [Ca21]i peak was
higher than under maximally aggregating conditions; however, the [Ca21]i decayed to an elevated steady state (Fig. 5 D),
similar to nonspiking mature peripheral cells (Fig. 2 B).
Aggregation of CD3 and CD4 evoked a biphasic calcium signaling response in mature CD5high thymocytes that
was largely independent of the receptor aggregation status.
(Fig. 5, E and F). The only significant effect of aggregation
on mature cells was a higher mean peak [Ca21]i (Fig. 5, bold
line) induced under conditions of maximal receptor engagement but minimal receptor aggregation. Mature peripheral
CD41 lymph node lymphocytes responded similarly to
mature thymocytes. Peripheral CD41 cells exhibited a biphasic calcium signaling response regardless of the streptavidin concentration used for stimulation (Fig. 5, G and H).
Thus, only DP CD5low and CD5int thymocytes have the
capacity to vary their calcium responses to changes in
TCR avidity.
CD28 Enhances the Calcium Response to CD3/CD4 Coaggregation. For most thymocytes, CD4 is functionally dissociated from the TCR complex due to its engagement by
MHC class II expressed on thymic epithelium. This dissociation inhibits the participation of CD4-associated tyrosine
kinase Lck in TCR signaling (20). Thus, freshly isolated
immature CD41CD81 thymocytes do not respond to isolated TCR/CD3 signals and require CD4 costimulation to
induce a calcium response (Fig. 1 D). Coengagement of
TCR/CD3 and coactivators such as CD4 allow Lck to
participate in TCR signaling (Fig. 1 A; reference 21).
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CD28 does not cooperate with the TCR to induce a
calcium response in freshly isolated lymphocytes (Fig. 1)
because it does not recruit Lck to the complex (22). To
determine whether CD28 signaling could modulate the
TCR-mediated [Ca21]i response when Lck was available,
we examined the calcium response to coengagement of
CD3, CD4, and CD28. The amplitude of the initial calcium rise was significantly higher in the presence of CD28
costimulation (Fig. 6, broken lines) than in its absence
(solid lines). This was true both at maximally (Fig. 6 A;
1.0 mg/ml streptavidin) and minimally (Fig. 6 B; 5 mg/ml
streptavidin) aggregating concentrations of streptavidin. Interestingly, CD28 significantly enhanced the spiking activity of thymocytes, even at high concentrations of streptavidin (Fig. 6 B, inset), when spikes are not ordinarily
observed.
Thus, although CD28 alone cannot cooperate with
CD3/TCR to generate calcium signals in immature thymocytes, it does modify the CD3/CD4 response. In fact,
CD28 costimulation appears to mimic the effect of increased
receptor aggregation on calcium signaling, even under conditions of minimal aggregation.
Calcium Signaling Patterns Correlate with Thymocyte Death.
The observed correlation between receptor avidity/aggregation and calcium signaling and the ability of CD28 to
convert biphasic to spiking responses is consistent with an
underlying role for calcium in thymocyte fate determination. Because the in vitro induction of thymocyte death
and maturation requires immobilized antibody, we used
microspheres to cross-link the TCR complex and corecep-
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Figure 6. The effect of CD28 on the calcium response to CD3/CD4
aggregation. The calcium responses of CD41CD81 thymocytes were
triggered by coengagement of CD3, CD4, (solid line), and CD28 (broken
line) induced by high (1.0 mg/ml streptavidin; A) and low (5.0 mg/ml
streptavidin; B) receptor aggregation. The mean response is shown, as
well as the responses of individual cells (inset). This effect of CD28 on
calcium was observed in three separate experiments.

tors in parallel calcium signaling and thymocyte maturation
experiments. Using this approach, coaggregation of CD3
and CD4 evoked a biphasic calcium response (Fig. 7 A)
similar to that evoked by high concentrations of soluble
streptavidin (Fig. 5, D and F, and Fig. 6 B). Coengagement
of CD3, CD4, and CD28 resulted in a spiking calcium response within many cells and a greater elevation in the
mean peak and plateau [Ca21]i compared with CD3/CD4
stimulation (Fig. 7 B). This effect of CD28 was similar to
the CD28-mediated augmentation of the calcium signal after aggregation with soluble streptavidin (Fig. 6).
We next examined the effect of CD3, CD4, and CD28
stimulation on CD41CD81 thymocyte fate in vitro. Consistent with previous studies using plate-bound antibody,
microspheres treated with CD3 and CD4 induced activation of all thymocytes (as reflected by upregulation of CD5;
Fig. 7 C) but not death (Fig. 7 D). CD28 coengagement
caused a marked and specific increase in thymocyte death.
(Fig. 7 D).

Discussion
In this report, we demonstrate that TCR/CD3-mediated Ca21 signaling patterns differ in developing thymo949
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cytes depending on (a) the maturation stage, (b) the extent of
TCR aggregation, and (c) the participation of costimulatory
or coactivating molecules. Notably, immature CD41CD81
thymocytes, whose developmental responses are known to
vary with the nature of TCR signals, have the unique capacity to decode distinct TCR signals by generating distinct calcium responses. Our data demonstrate that low avidity TCR
engagement of CD41CD81 thymocytes initiated a single biphasic Ca21 signal, whereas high avidity TCR engagement
initiated an oscillatory or spiking Ca21 signaling pattern.
We observed markedly heterogeneous Ca21 signaling
patterns within thymocytes after CD3/CD4 aggregation
and found that these signaling differences correlated with
the thymocyte developmental stage. As one might expect,
the most immature thymocytes (CD42CD82CD5low), which
express little if any TCR on their surfaces, did not respond to TCR stimulation. Mature thymocyte populations
(CD41CD82CD5high and CD41CD81CD5high) exhibited
a biphasic Ca21 signaling response that was also typical of
mature peripheral T cells. In contrast, immature CD41
CD81 cells (CD41CD81CD5low and CD41CD81CD5int),
the targets of most selection events that occur within the
thymus, could vary their Ca21 signaling responses. Immature DP thymocytes typically exhibited an initial transient
elevation of [Ca21]i after receptor aggregation that subsequently decayed to an elevated steady state or oscillated depending upon the degree of receptor aggregation. Within a
homogeneously immature population of fetal thymocytes,
CD3/CD4 evoked only Ca21i spikes in responding cells. In
contrast, [Ca21]i spikes could not be evoked in mature, peripheral murine T cells regardless of the extent of TCR/
CD3 aggregation. Together, these data indicate that the capacity to generate Ca21 spikes is restricted to immature
CD41CD81 thymocytes.
The ability to generate biphasic or oscillatory Ca21i signaling responses based upon the extent of TCR/CD3 aggregation is a unique characteristic of immature CD41
CD81 thymocytes, which suggests that Ca21 could play a
role in determining the developmental fate of these cells.
CD41CD81 thymocytes are the targets of both negative
and positive selection and will die or differentiate depending on the nature of the TCR signal they receive. Although
the precise mechanism by which TCR engagement can
specify negative and positive developmental responses is
unknown, data clearly suggest that differences in TCR affinity and aggregation, collectively referred to as avidity,
are key (1, 4). Receptor avidity and the maturational response are modulated by subtle structural alterations in
peptide ligands. This ability of similar peptide ligands to induce positive or negative selection also correlates with the
mean amplitude of the calcium response evoked by each
ligand (14, 23).
By varying the concentration of our receptor-engaging
reagent, streptavidin, we have been able to modulate the
extent of TCR/CD3 aggregation and, hence, mimic differences in antigen–TCR avidity. We find that avidity differences can be translated into distinct patterns of Ca21 signaling within thymocytes. High avidity TCR interactions,

Figure 7. Correlation between calcium signaling response and thymocyte
fate. Calcium signaling responses of single thymocytes after aggregation of (A)
CD3 and CD4 or (B) CD3, CD4, and
CD28 with streptavidin-coated microspheres (see Materials and Methods).
The mean calcium response is indicated
in each plot with a bold line. The thymocyte/microsphere ratio was z1:1,
and all responding cells contacted a single microsphere. In these experiments,
1/18 cells (A) exhibited a single spike
subsequent to the initial transient [Ca21]i
elevation, whereas 18/32 responding
cells (B) exhibited one or more calcium
spikes $50% of the initial peak [Ca21]i.
Arrows indicate the times when microspheres were added to the recording
chamber. (C) CD3/CD4-coated microspheres induced increased CD5 expression (solid line) compared with control
antibody–treated cells (broken line) but
not apoptosis (D, third bar from left).
(D) CD3-, CD4-, and CD28-coated
microspheres induced a significant increase in the number of apoptotic cells.
These maturation and calcium results
are representative of at least three separate experiments with microspheres.

such as those associated with negative selection of DP thymocytes, evoked [Ca21]i spikes and an elevation in the
mean [Ca21]i amplitude, whereas low avidity interactions,
which are associated with positive selection, initiated a
biphasic calcium signal. These findings imply that signals
that induce Ca21 spikes will induce thymocyte apoptosis,
whereas those that generate a single biphasic response will
initiate maturation. It should be noted that semimature
CD41HSAhigh cells can also undergo negative selection (24,
25). We did not look specifically at the calcium responses
of this population; however, we did not observe spiking responses in CD41 single-positive cells. Thus, negative selection of CD41HSAhigh thymocytes likely occurs by a distinct
mechanism from immature DP thymocytes.
Interestingly, the biphasic Ca21 signal generated by low
avidity CD3 and CD4 engagement was converted to a
spiking pattern by CD28, which provides an apoptotic signal in thymocytes (7–9). CD28 also increased the peak amplitude of Ca21i oscillations and the mean [Ca21]i after high
avidity engagement of CD3/CD4. These data are consistent with the observation that peptides capable of triggering
negative selection cause higher mean amplitude calcium elevations than those that trigger positive selection (14). The
mechanism underlying this effect of CD28 may be related
to a recent observation that CD28 engagement amplifies
TCR-mediated signaling (26) by promoting the redistribution and clustering of activation molecules, possibly within
kinase-rich microdomains (27), at the site of TCR engagement. Thus CD28-mediated amplification of calcium spiking activity in thymocytes may reflect its ability to change
the structure and makeup of the TCR signaling complex.
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Our data are consistent with previous studies indicating
that TCR/CD3 engagement with CD2 or CD4 induces
maturation to the CD4 lineage in vitro (5). In fact, TCR
engagement without aggregation is associated with positive
selection (28). In these previous studies, stimulation was
provided by saturating levels of plate-bound rather than
soluble antibody. In our system, positive selecting conditions induced by high levels of soluble streptavidin (maximal receptor engagement but minimal receptor aggregation) are associated with biphasic calcium signals. We also
duplicated conditions that induce thymocyte activation
versus death using antibody fixed to microspheres. These
experiments demonstrated that a biphasic calcium signaling
response is associated with cell activation and repetitive
spikes are associated with thymocyte apoptosis.
The significance of these findings is underscored by recent studies indicating that calcium alone can specify different patterns of gene transcription in lymphocytes and that
specificity is encoded in the amplitude and/or frequency of
cytoplasmic Ca21 changes (15, 16, 29). A variety of calciumregulated protein kinases and phosphatases expressed by
lymphocytes, including calcineurin, calmodulin-dependent
kinase II (CaMKII) and protein kinase Cg, could translate
different Ca21i signaling patterns (30, 31). Each is expressed
in thymocytes and is responsive to TCR signals (32–34).
Notably, CaMKII activity is modulated by the [Ca21]i oscillation frequency (30). These or other calcium-sensitive
enzymes, which can distinguish between calcium amplitude– or frequency–encoded receptor signals, may initiate
different patterns of gene expression and specify distinct developmental fates.
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The molecular basis for Ca21 spikes has not been defined
in murine or human thymocytes, although calcium oscillations have been extensively studied in human peripheral
lymphocytes (35, 36). It is generally accepted that [Ca21]i
initially increases due to inositol 1,4,5-trisphosphate–mediated release from intracellular stores and is sustained by extracellular influx. In primary human T cells, [Ca21]i oscillations are initiated by transient feedback inhibition of rising
calcium on its own influx (37, 38), and [Ca21]i levels are
reduced by uptake into mitochondria and reuptake into the
endoplasmic reticulum (39, 40). As Ca21i falls, inhibition of
its own influx is relieved. The net result is that [Ca21]i increases and decreases due to the sequential and repetitive
activation and inactivation of influx under conditions of
constant TCR stimulation (36). In thymocytes, we found
that both calcium spikes and steady state elevations in
[Ca21]i were inhibited by removal of extracellular calcium,
suggesting that extracellular [Ca21] plays a role in both signaling responses (data not shown).
Several additional mechanisms may determine the pattern of calcium signaling. For example, in human T lym-

phocytes the plasma membrane potential strongly influences the magnitude of calcium influx and, consequently,
the pattern of signaling. Sequential activation and inactivation of voltage-dependent and calcium-activated potassium
channels has been shown to rapidly modulate the membrane potential and the driving force for calcium influx
(41). Other studies have demonstrated that ryanodine receptors play a role in the generation of calcium oscillations
in human T cells (42, 43). Finally, in human B lymphocytes, [Ca21]i oscillations result from repetitive calcium release and reuptake into the endoplasmic reticulum, whereas
sustained calcium elevations require extracellular calcium
influx (44).
In summary, our data provide evidence that Ca21i, which
is one of the most proximal molecular reflections of TCR
signaling, underlies the ability of immature CD41CD81 thymocytes to distinguish between low and high avidity TCR
signals. The unique ability of CD41CD81 thymocytes to
generate distinct Ca21i signaling responses (depending upon
the avidity of the TCR signal) strongly suggests that calcium
plays a central role in regulating thymic selection.
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